B

Beam Therapeutics

Develops base editing–based precision medicines

Manufacturing Science & Technology Co-op - MS&T

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Internship · Winter 2027Durham, NC, USA$24 - $34 /hr

About the Job

Requirements

  • Currently pursuing a Bachelor's or Master's degree in Chemical Engineering, Bioengineering, Biomedical Engineering, Biotechnology, or a related scientific discipline.
  • Must be entering the third or fourth year of undergraduate study or currently pursuing a Master's degree.
  • Applicants must be currently enrolled in a degree-granting college or university program and maintain student status throughout the co-op.
  • Have a strong interest in biopharmaceutical manufacturing, cell therapy, sterile manufacturing, or Good Manufacturing Practice (GMP) operations.
  • Be proficient with Microsoft Office applications, including Excel, Word, and PowerPoint.
  • Be able to work onsite in Durham, North Carolina, on a hybrid schedule requiring onsite attendance 4–5 days per week.
  • Be able to occasionally enter manufacturing and laboratory environments while following applicable gowning and safety requirements.
  • Be able to sit, stand, and use a computer for extended periods.

Responsibilities

  • Develop a project plan, define objectives and desired outcomes, engage cross-functional stakeholders, and execute against established timelines.
  • Support lifecycle management of the site's Aseptic Process Simulation (APS) program, including protocol development, execution support, data analysis, and report generation.
  • Support Pre-License Inspection (PLI) readiness activities, including document review, data verification, and inspection support preparation.
  • Prepare technical summaries and presentations for MSAT leadership and cross-functional stakeholders.
  • Maintain compliant documentation practices in accordance with Good Manufacturing Practice (GMP) requirements.

About the Company

Beam Therapeutics

Develops base editing–based precision medicines

Beam Therapeutics uses base editing to develop precision genetic medicines aimed at correcting disease-causing mutations. It focuses on R&D and collaborates with pharmaceutical companies and research institutions to fund and advance therapies, earning revenue through partnerships, licensing, upfront and milestone payments, and royalties. The company targets genetic disorders such as sickle cell disease with the goal of delivering lifelong cures, differentiating itself through its emphasis on durable genetic remedies and a science-driven, values-led culture.

Company size
501-1,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Beam Therapeutics

See more jobs